Results 1 to 10 of about 46,760 (168)

In Vivo Biocompatibility of an Innovative Elastomer for Heart Assist Devices. [PDF]

open access: yesPolymers (Basel), 2022
Cardiac surgical approaches require the development of new materials regardless of the polyurethanes used for pulsatile blood pumps; therefore, an innovative biomaterial, a copolymer of poly(ethylene terephthalate) and dimer fatty acid (dilinoleic acid) modified with D-glucitol, hereafter referred to as PET/DLA, has been developed, showing non ...
Zawidlak-Węgrzyńska B   +5 more
europepmc   +4 more sources

Safety and efficacy of short-term ventricular assist devices in paediatric heart transplant candidates: a systematic review and single arm meta-analysis [PDF]

open access: yesBMC Cardiovascular Disorders
Background Safety and efficacy of short-term ventricular assist devices (VAD) remains incompletely understood, particularly in younger children. This systematic review and meta-analysis aims to evaluate outcomes, including bridging success, complications,
Nathanael Q.E. Yap   +10 more
doaj   +2 more sources

Incidence of malignancies after lung transplantation and their effect on the outcome. 26 years' experience

open access: yesHeliyon, 2023
Background: Malignancy is a significant, life-limiting complication after lung transplantation (LuTx) and the second common long-term cause of death. We aimed to investigate its incidence and effect on the outcome.
Konstantina Spetsotaki   +5 more
doaj   +1 more source

Trends in contemporary advanced heart failure management: an in-depth review over 30 years of heart transplant service in Hong Kong

open access: yesKorean Journal of Transplantation, 2022
Background : The year 2022 marks the 30th anniversary of heart transplant service in Hong Kong (HK). In this study, we describe prevailing trends and outcomes of advanced heart failure (AHF), including heart transplantations (HTx), in HK over the past 30
Yue Yan Katherine Fan   +10 more
doaj   +1 more source

Mechanical Circulatory Assist Devices: Time for More Attention by Iranian Cardiologists

open access: yesJournal of Tehran University Heart Center, 2022
-
Haleh Ashraf   +2 more
doaj   +1 more source

Resultados del uso de dispositivos de asistencia ventricular de corta-media duración como puente al trasplante cardiaco

open access: yesCirugía Cardiovascular, 2022
Resumen: Introducción y objetivo: Evaluar el resultado del uso de dispositivos de asistencia ventricular de corta-media duración, tipo Centrimag e Impella, en pacientes en INTERMACS 1-3, como puente al trasplante cardiaco. Material y método: Del 2015 al
Carlos Domínguez-Massa   +12 more
doaj   +1 more source

Thermoplastic Elastomers: Materials for Heart Assist Devices [PDF]

open access: yesPolymers in Medicine, 2016
Heart assisting devices have become a standard element in clinical practice and provide support for the traditional methods of treating heart disease. Regardless of the construction of VAD (ventricular assist devices), there are crucial requirements that have to be met by the construction materials: high purity, desired physical, chemical and ...
Agnieszka, Piegat, Mirosława El, Fray
openaire   +2 more sources

An Up-to-Date Literature Review on Ventricular Assist Devices Experience in Pediatric Hearts

open access: yesLife, 2022
Ventricular assist devices (VAD) have gained popularity in the pediatric population during recent years, as more and more children require a heart transplant due to improved palliation methods, allowing congenital heart defect patients and children with ...
Ștefana Maria Moisă   +10 more
doaj   +1 more source

Laparoscopic sleeve gastrectomy in obese patients with ventricular assist devices: a data note

open access: yesBMC Research Notes, 2020
Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT ...
Adrian daSilva-deAbreu   +10 more
doaj   +1 more source

Anesthetic Management of Left Ventricular Assist Device Exchange in a Patient with Intracranial Hemorrhage

open access: yesJournal of Tehran University Heart Center, 2020
The gold standard treatment for end-stage heart failure is heart transplantation; however, the rate of transplantation remains inadequate because of the paucity of organ donation.
Nevri̇ye Salman   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy